Jaguar Health Inc. Common Stock (JAGX)

About JAGX

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. Its lead prescription…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

47

Website

jaguar.health

Fundamentals

1-day range

$0.7407$1

Market cap

$4.91M

P/E (trailing)

—

P/E (forward)

-0.16

EPS (trailing)

$-695.50

Dividend yield

—

Beta

-0.05

Avg. volume

120.3K

Dividend pay date

June 7, 2019

Jaguar Health Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• JAGX

  Jaguar Health Inc. Common Stock

  $0.81

  ▼ 6.36%
  Market cap $4.91MP/E —
  $0.725$85.4
• APVO

  Aptevo Therapeutics Inc. Common Stock

  $2.36

  ▼ 2.48%
  Market cap $4.92MP/E 0.00
  $2.3$48.78
• LABT

  Lakewood-Amedex Biotherapeutics Inc. Common Stock

  $2.3

  ▼ 4.56%
  Market cap $5.12MP/E —
  $0.366$9.82
• GOVX

  GeoVax Labs Inc. Common Stock

  $0.7195

  ▲ 0.35%
  Market cap $5.34MP/E —
  $0.59$19.2
• BGMS

  Bio Green Med Solution Inc. Common Stock

  $0.86

  ▼ 3.37%
  Market cap $5.35MP/E 0.18
  $0.5664$8.82
• ZSTK

  ZeroStack Corp. Common Stock

  $5.51

  ▼ 6.29%
  Market cap $4.21MP/E —
  $1.32$47
• NCNA

  NuCana plc American Depositary Share

  $1.79

  ▲ 21.43%
  Market cap $5.62MP/E 0.01
  $1.21$7.22

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Jaguar Health’s Napo Pharma Satisfies Conditions Required To Receive Payment Of Non-Dilutive $2M Holdback Amount From Future Pak Related To US Commercial Licensing Agreement
  Benzinga · 8/5/2026